Diacylglycerol lipase
From Wikipedia, the free encyclopedia
|
diacylglycerol lipase, alpha
|
|
| Identifiers | |
| Symbol | DAGLA |
| Alt. Symbols | C11orf11 |
| Entrez | 747 |
| HUGO | 1165 |
| RefSeq | NM_006133 |
| UniProt | Q9Y4D2 |
| Other data | |
| Locus | Chr. 11 q12.3 |
|
diacylglycerol lipase, beta
|
|
| Identifiers | |
| Symbol | DAGLB |
| Entrez | 221955 |
| HUGO | 28923 |
| RefSeq | NM_139179 |
| UniProt | Q8NCG7 |
| Other data | |
| Locus | Chr. 7 p22.1 |
Diacylglycerol lipase, also known as DAG lipase, DAGL or DGL, is a key enzyme in the biosynthesis of the endocannabinoid 2-arachidonoylglycerol.[1] It catalyzes the hydrolysis of diacylglycerol releasing a free fatty acid and monoacylglycerol.
Two separate genes encoding DGL enzymes have been cloned, termed DGLα (DAGLA) and DGLβ (DAGLB), that share 33% sequence identity.
[edit] Inhibitors
The enzyme has been described to be inhibited selectively by two agents, RHC80267 and tetrahydrolipstatin.
[edit] References
- ^ Bisogno, T. et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell. Biol. 2003 (163)3:463. Article
[edit] External links
|
||||||||||||||||||||
